Abstract: Disclosed is a liposomal composition for treatment of cancer, which includes at least one PEG-Phospholipid conjugated molecule, cholesterol, and at least one phospholipid.
Type:
Grant
Filed:
April 15, 2016
Date of Patent:
November 13, 2018
Assignees:
MASHHAD UNIVERSITY OF MEDICAL SCIENCE, TEHRAN UNIVERSITY OF MEDICAL SCIENCE